首页> Scientific reports> Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer.

Phase II dose titration study of regorafenib in progressive unresectable metastatic colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Takeshi,Kato

第一单位： Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.

作者： Takeshi,Kato ^[1] ; Toshihiro,Kudo ^[2] ; Yoshinori,Kagawa ^[3] ; Kohei,Murata ^[3] ; Hirofumi,Ota ^[4] ; Shingo,Noura ^[5] ; Junichi,Hasegawa ^[5] ; Hiroshi,Tamagawa ^[6] ; Katsuya,Ohta ^[7] ; Masakazu,Ikenaga ^[7] ; Susumu,Miyazaki ^[8] ; Takamichi,Komori ^[8] ; Mamoru,Uemura ^[9] ; Junichi,Nishimura ^[9] ; Taishi,Hata ^[9] ; Chu,Matsuda ^[9] ; Taroh,Satoh ^[10] ; Tsunekazu,Mizushima ^[9] ; Yuko,Ohno ^[11] ; Hirofumi,Yamamoto ^[9] ; Yuichiro,Doki ^[9] ; Hidetoshi,Eguchi ^[9]

作者单位： Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan. ^[1] Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan. tkudo@mc.pref.osaka.jp. ^[2] Department of Colorectal Surgery, Kansai Rosai Hospital, Amagasaki, Japan. ^[3] Department of Digestive Surgery, Ikeda City Hospital, Ikeda, Japan. ^[4] Department of Surgery, Osaka Rosai Hospital, Sakai, Japan. ^[5] Department of Surgery, Otemae Hospital, Osaka, Japan. ^[6] Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan. ^[7] Department of Surgery, Osaka General Medical Center, Osaka, Japan. ^[8] Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan. ^[9] Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan. ^[10] Department of Mathematical Health Science, Graduate School of Medicine, Osaka University, Suita, Japan. ^[11]